New! Sign up for our free email newsletter.
Science News
from research organizations

Anticholinergic cognitive burden scale helps identify risk of adverse outcomes

Comparative associations between measures of anticholinergic burden and adverse clinical outcomes

Date:
November 21, 2017
Source:
American Academy of Family Physicians
Summary:
Anticholinergic burden assessed with the Anticholinergic Cognitive Burden Scale consistently shows dose-response relationships with a variety of adverse outcomes.
Share:
FULL STORY

Anticholinergic burden assessed with the Anticholinergic Cognitive Burden Scale consistently shows dose-response relationships with a variety of adverse outcomes. In a study of long-term associations between adverse clinical outcomes in older adults and three scales for anticholinergic burden (the cumulative effect of using multiple medications that block the effects of acetylcholine in the body), the ACB showed the strongest, most consistent dose-response relationships with risk of all four adverse outcomes studied: emergency department visits, all-cause hospitalizations, hospitalizations for fractures, and incident dementia.

Among those 65 to 74 years old, for example, when going from an ACB score of 1 to a score of 4 or greater, individuals' adjusted odds ratio increased from 1.41 to 2.25 for emergency department visits; from 1.32 to 1.92 for all-cause hospitalizations; from 1.10 to 1.71 for fracture-specific hospitalizations; and from 3.13 to 10.01 for incident dementia. Because medications with anticholinergic properties comprise 30 to 50 percent of all medications commonly prescribed to older adults, the authors suggest that the ACB may be a useful tool to identify high-risk populations for future research.


Story Source:

Materials provided by American Academy of Family Physicians. Note: Content may be edited for style and length.


Journal Reference:

  1. Wen-Han Hsu, Yu-Wen Wen, Liang-Kung Chen, Fei-Yuan Hsiao. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes. The Annals of Family Medicine, 2017; 15 (6): 561 DOI: 10.1370/afm.2131

Cite This Page:

American Academy of Family Physicians. "Anticholinergic cognitive burden scale helps identify risk of adverse outcomes." ScienceDaily. ScienceDaily, 21 November 2017. <www.sciencedaily.com/releases/2017/11/171121095225.htm>.
American Academy of Family Physicians. (2017, November 21). Anticholinergic cognitive burden scale helps identify risk of adverse outcomes. ScienceDaily. Retrieved June 19, 2024 from www.sciencedaily.com/releases/2017/11/171121095225.htm
American Academy of Family Physicians. "Anticholinergic cognitive burden scale helps identify risk of adverse outcomes." ScienceDaily. www.sciencedaily.com/releases/2017/11/171121095225.htm (accessed June 19, 2024).

Explore More

from ScienceDaily

RELATED STORIES